13F filer · CIK 1344551 ↗
Assetmark, Inc
You are looking at Q3 2022. See the latest, Q3 2026 →
Reported value
$21.39B
−4.1% on the quarter before
Positions
1,575
117 new · 100 sold out
Top 10
31.5%
of the value
Est. gain
−$1.02B
on stocks held all quarter
Est. return
−5.0%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Assetmark, Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 48% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$210.2MAdded · 0.2% → 1.2%+2,051,284 shares
- SPDR Ser Tr~$209.6MAdded · 0.0% → 1.0%+3,311,699 shares
- Ishares Tr~$117.0MAdded · 0.5% → 1.0%+1,218,696 shares
- SPDR Ser Tr~$112.7MNew · 0.0% → 0.5%+1,010,640 shares
- Vertex Pharmaceuticals Inc~$110.1MAdded · 0.0% → 0.5%+380,279 shares
- Select Sector SPDR Tr~$83.8MAdded · 0.1% → 0.5%+588,033 shares
- Vanguard World Fd~$81.7MAdded · 4.3% → 4.6%+908,318 shares
- Vanguard World Fd~$66.7MAdded · 4.6% → 4.9%+382,535 shares
- Expeditors Intl Wash Inc~$61.5MAdded · 0.0% → 0.3%+696,312 shares
- Ishares Tr~$61.1MAdded · 0.3% → 0.5%+1,027,371 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$209.9MCut · 5.5% → 4.7%−2,585,002 shares
- Ishares Tr~$199.3MCut · 1.0% → 0.0%−1,899,840 shares
- SPDR Gold Tr~$138.4MCut · 0.7% → 0.0%−897,236 shares
- Ishares Tr~$83.8MCut · 0.3% → 0.0%−293,298 shares
- SPDR Ser Tr~$81.8MCut · 4.1% → 3.9%−892,469 shares
- Ishares Tr~$76.6MCut · 0.9% → 0.5%−795,504 shares
- First Tr Exchange-Traded Fd~$74.2MCut · 0.3% → 0.0%−534,486 shares
- Nushares ETF Tr~$56.9MCut · 0.3% → 0.1%−2,798,725 shares
- SPDR Index Shs Fds~$48.6MCut · 0.2% → 0.0%−1,027,680 shares
- Simon Ppty Group Inc New~$47.7MCut · 0.2% → 0.0%−531,257 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard World FdMEGA GRWTH IND · shares +6.8% · price −4.1% | 4.9% | $1.04B | −$41.4M | ||||||||
| Ishares Tr1 3 YR TREAS BD · shares −17% · price −1.9% | 4.7% | $998.4M | −$19.4M | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares −0.3% · price −5.4% | 4.6% | $992.2M | −$56.2M | ||||||||
| Vanguard World FdMEGA CAP VAL ETF · shares +9.1% · price −6.5% | 4.6% | $978.6M | −$62.5M | ||||||||
| SPDR Ser TrBLOOMBERG 1-3 MO · shares −9.0% · price +0.1% | 3.9% | $828.9M | +$994,995 | ||||||||
| Vanguard Index FdsSM CP VAL ETF · shares +2.9% · price −4.3% | 2.0% | $429.3M | −$18.7M | ||||||||
| Vanguard Scottsdale FdsMTG-BKD SECS ETF · shares −1.6% · price −5.7% | 1.9% | $400.4M | −$24.2M | ||||||||
| Ishares TrISHS 1-5YR INVS · shares +5.1% · price −2.5% | 1.8% | $388.7M | −$9.5M | ||||||||
| Ishares TrCORE MSCI EAFE · shares +0.7% · price −10.5% | 1.7% | $362.8M | −$42.2M | ||||||||
| Ishares IncCORE MSCI EMKT · shares −1.7% · price −12.4% | 1.5% | $323.4M | −$45.8M | ||||||||
| Vanguard Index FdsMCAP VL IDXVIP · shares +5.0% · price −6.0% | 1.4% | $306.8M | −$18.6M | ||||||||
| Ishares TrUS TREAS BD ETF · shares −2.3% · price −4.8% | 1.4% | $296.2M | −$14.8M | ||||||||
| Ishares TrIBOXX INV CP ETF · shares −14% · price −6.9% | 1.4% | $293.0M | −$21.7M | ||||||||
| Vanguard Index FdsMCAP GR IDXVIP · shares +9.3% · price −2.8% | 1.4% | $290.0M | −$7.5M | ||||||||
| Ishares TrSHORT TREAS BD · shares −8.3% · price −0.1% | 1.3% | $280.6M | −$255,811 | ||||||||
| Ishares Tr20 YR TR BD ETF · shares +511% · price −10.8% | 1.2% | $251.3M | −$5.0M | ||||||||
| Ishares Tr0-5YR HI YL CP · shares +4.9% · price −1.5% | 1.2% | $247.8M | −$3.6M | ||||||||
| Ishares TrISHS 5-10YR INVT · shares −0.01% · price −5.4% | 1.1% | $245.7M | −$14.1M | ||||||||
| MicrosoftCOM · shares +7.2% · price −9.3% | 1.1% | $234.8M | −$22.5M | ||||||||
| Ishares Tr7-10 YR TRSY BD · shares +110% · price −6.2% | 1.0% | $223.7M | −$7.0M | ||||||||
| Vanguard Bd Index FdsTOTAL BND MRKT · shares −7.5% · price −5.2% | 1.0% | $221.8M | −$12.2M | ||||||||
| Ishares Tr3 7 YR TREAS BD · shares −1.0% · price −4.2% | 1.0% | $221.4M | −$9.8M | ||||||||
| Vanguard Charlotte FdsTOTAL INT BD ETF · shares −11% · price −3.7% | 1.0% | $220.8M | −$8.4M | ||||||||
| Vanguard Index FdsSML CP GRW ETF · shares +1.1% · price −1.0% | 1.0% | $217.7M | −$2.1M | ||||||||
| SPDR Ser TrBBG CONV SEC ETF · shares +247,882% · price −1.7% | 0.98% | $209.7M | −$1,431 | ||||||||
| Total · 1,575 positions | 100% | $21.39B | −$1.02B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 1,385 stocks held throughout, down $1.02B (−5.0%).
- Alphabet25:1 split+$17.2M+10%
- Devon Energy Corp New+$8.6M+9%
- Builders Firstsource Inc+$7.2M+10%
- Cadence+$6.8M+9%
- Regeneron Pharmaceuticals+$6.6M+17%
- Vanguard World Fd−$41.4M−4%
- Ishares Tr−$42.2M−10%
- Ishares Inc−$45.8M−12%
- Vanguard Index Fds−$56.2M−5%
- Vanguard World Fd−$62.5M−7%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | $59.48B+2% | SEC ↗ |
| Q2 2026 | Jul 30, 2026 | $58.17B+19% | SEC ↗ |
| Q1 2026 | May 6, 2026 | $49.04B+0% | SEC ↗ |
| Q4 2025 | Jan 23, 2026 | $49.04B+5% | SEC ↗ |
| Q3 2025 | Nov 6, 2025 | $46.65B+10% | SEC ↗ |
| Q2 2025 | Aug 4, 2025 | $42.36B+16% | SEC ↗ |
| Q1 2025 | May 6, 2025 | $36.41B−1% | SEC ↗ |
| Q4 2024 | Feb 6, 2025 | $36.81B+5% | SEC ↗ |
| Q3 2024 | Nov 1, 2024 | $34.92B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $32.33B+5% | SEC ↗ |
| Q1 2024 | May 7, 2024 | $30.76B+11% | SEC ↗ |
| Q4 2023 | Feb 9, 2024 | $27.67B+11% | SEC ↗ |
| Q3 2023 | Oct 27, 2023 | $25.01B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $25.49B+5% | SEC ↗ |
| Q1 2023 | May 5, 2023 | $24.19B+5% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $23.07B+8% | SEC ↗ |
| Q3 2022 | Nov 1, 2022 | $21.39B−4% | SEC ↗ |
| Q2 2022 | Aug 3, 2022 | $22.31B−7% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $23.89B−2% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $24.34B+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $22.32B+4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $21.56B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $19.39B+8% | SEC ↗ |
| Q4 2020 | Feb 10, 2021 | $17.95B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $15.50B+11% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $13.98B+18% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $11.81B−10% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $13.16B+10% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $11.95B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $12.27B+11% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $11.07B+7% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $10.36B−6% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $11.00B+8% | SEC ↗ |
| Q2 2018 | Aug 1, 2018 | $10.18B+5% | SEC ↗ |
| Q1 2018 | May 16, 2018 | $9.66B−0% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $9.70B+10% | SEC ↗ |
| Q3 2017 | Nov 8, 2017 | $8.79B+11% | SEC ↗ |
| Q2 2017 | Aug 15, 2017 | $7.95B+4% | SEC ↗ |
| Q1 2017 | Sep 15, 2017 (amended) | $7.61B+12% | SEC ↗ |
| Q4 2016 | Sep 15, 2017 (amended) | $6.81B+4% | SEC ↗ |
| Q3 2016 | Sep 15, 2017 (amended) | $6.58B+11% | SEC ↗ |
| Q2 2016 | Sep 15, 2017 (amended) | $5.95B+4% | SEC ↗ |
| Q1 2016 | Sep 15, 2017 (amended) | $5.73B | SEC ↗ |